Using our system-level model, we previously simulated ADA production induced by adalimumab, a fully anti-TNF alpha IgG1 mAb used to treat various inflammatory and autoimmune diseases, with a danger signal of 350 ng LPS [47] (Figure 4(e)). This evidence concerns the gene TNF and autoimmune disease.